Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-08

Clinical Trial Update: A Clinical Trial to Study the Effects of a Fixed Dose Combination of Diclofenac and Eperisone Hydrochloride With Plain Eperisone Hydrochloride in Patients With Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a fixed-dose combination of diclofenac and eperisone hydrochloride against plain eperisone in low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac (diclofenac)
  • Diclofenac and Eperisone Hydrochloride Fixed-Dose Combination (diclofenac; eperisone hydrochloride)
  • Eperisone hydrochloride (Eperisone)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Acute Musculoskeletal Spasm Due to Low Back Pain | Phase 3 | Status: COMPLETED